BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2287110)

  • 1. [Analyses of factors contributing to the erectile dysfunction with aging by nocturnal penile tumescence, penile blood pressure index and papaverine test].
    Aoki M; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1633-41. PubMed ID: 2287110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiological analysis of male diabetic erectile dysfunction with particular emphasis on findings of vascular and neurological examinations].
    Yamaguchi Y; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1474-83. PubMed ID: 7990296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic tests for impotence: a comparison of papaverine injection with the penile-brachial index and nocturnal penile tumescence monitoring.
    Abber JC; Lue TF; Orvis BR; McClure RD; Williams RD
    J Urol; 1986 May; 135(5):923-5. PubMed ID: 3959242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence.
    Shabsigh R; Fishman IJ; Shotland Y; Karacan I; Dunn JK
    J Urol; 1990 May; 143(5):924-7. PubMed ID: 2184255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penile-brachial pressure index as a guide for the dosage of intracavernous injection of papaverine.
    Puppo P; de Rose AF; Pittaluga P; Germinale F; Caviglia C; Giuliani L
    Eur Urol; 1988; 14(3):210-3. PubMed ID: 3383931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of sexual function in male hemodialysis patients--analysis of the cause of erectile dysfunction].
    Suzuki N; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1995 Jun; 86(6):1098-107. PubMed ID: 7609352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-stratified cut-off points for the nocturnal penile tumescence measurement using Nocturnal Electrobioimpedance Volumetric Assessment (NEVA(®) ) in sexually active healthy men.
    Tok A; Eminaga O; Burghaus L; Herden J; Akbarov I; Engelmann U; Wille S
    Andrologia; 2016 Aug; 48(6):631-6. PubMed ID: 26498135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erectile response to visual erotic stimuli before and after intracavernosal papaverine, and its relationship to nocturnal penile tumescence and psychometric assessment.
    Bancroft J; Smith G; Munoz M; Ronald P
    Br J Urol; 1991 Dec; 68(6):629-38. PubMed ID: 1773296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical assessment of erectile dysfunction: a comparison of nocturnal penile tumescence monitoring and intracavernosal injections.
    Bancroft J; Malone N
    Int J Impot Res; 1995 Jun; 7(2):123-30. PubMed ID: 7496441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal penile tumescence in cigarette smokers with erectile dysfunction.
    Hirshkowitz M; Karacan I; Howell JW; Arcasoy MO; Williams RL
    Urology; 1992 Feb; 39(2):101-7. PubMed ID: 1736499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification of patterns of nocturnal penile tumescence with continuous monitoring of penile rigidity: analysis of various factors affecting erection].
    Yasumoto R; Kawano M; Tsurusaki K; Yoneda Y; Ishii K; Khono T; Kumata N; Fukui J; Hayashi S; Tsujino T; Umeda M
    Hinyokika Kiyo; 1996 Apr; 42(4):285-8. PubMed ID: 8693961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levodopa on nocturnal penile tumescence: a preliminary study.
    Horita H; Sato Y; Adachi H; Suzuki N; Kato R; Hisasue S; Suzuki K; Tsukamoto T
    J Androl; 1998; 19(5):619-24. PubMed ID: 9796623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
    Porst H
    Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening sequence for vasculogenic impotence.
    DePalma RG; Emsellem HA; Edwards CM; Druy EM; Shultz SW; Miller HC; Bergsrud D
    J Vasc Surg; 1987 Feb; 5(2):228-36. PubMed ID: 3820400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison between nocturnal penile tumescence (NPT) and artificial full erection].
    Aoki M; Kumamoto Y; Mori K; Yamaguti Y; Sato Y
    Hinyokika Kiyo; 1988 May; 34(5):825-31. PubMed ID: 3177125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in penile sensitivity following papaverine-induced erection in sexually functional and dysfunctional men.
    Rowland DL; Leentvaar EJ; Blom JH; Slob AK
    J Urol; 1991 Oct; 146(4):1018-21. PubMed ID: 1895416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on nocturnal penile tumescence (NPT) in healthy males study on age-related changes of NPT].
    Horita H; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1502-10. PubMed ID: 7990298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vasculogenic erectile impotence using penile duplex ultrasonography.
    Shabsigh R; Fishman IJ; Quesada ET; Seale-Hawkins CK; Dunn JK
    J Urol; 1989 Dec; 142(6):1469-74. PubMed ID: 2685366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is intracavernous injection of papaverine a reliable screening test for vascular impotence?
    Buvat J; Buvat-Herbaut M; Dehaene JL; Lemaire A
    J Urol; 1986 Mar; 135(3):476-8. PubMed ID: 3944889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.